Axonics, Inc. (AXNX) Tops Q4 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Axonics, Inc. (AXNX) Tops Q4 EPS by 3c

Axonics® Reports Fourth Quarter and Fiscal Year 2021 Financial Results

February 24, 2022 4:01 PM EST

Total revenue of $53.1 million in 4Q21, an increase of 53% year over year

Fiscal year 2022 revenue outlook of $234 million, an increase of 30% year over year

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the three months and fiscal year ended December 31, 2021.

We are proud of our fourth quarter and fiscal year 2021 results considering the... More